Functioning and disability in multiple sclerosis

References

• CompstonA, ColesA. Multiple Sclerosis. Lancet 2008;372:1502–1517.
   PubMed Web of Science ®Google Scholar
• ConfavreuxC, CompstonA. The natural story of MS. In: CompstonA, McDonaldIR, NoseworthyJ, LassmannH, MillerDH, SmithKJ, WekerleH, ConfavreuxC, editors.McAlpine's Multiple Sclerosis. 4th ed. London: Churchill Livingstone Elsevier; 2006. pp 183–269.
   Google Scholar
• FisnikuLK, BrexPA, AltmannDR, MiszkielKA, BentonCE, LanyonR, ThompsonAJ, MillerDH. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008;131:808–817.
   PubMed Web of Science ®Google Scholar
• ConfavreuxC, VukusicS. Age at disability milestones in multiple sclerosis. Brain 2006;129:595–605.
   PubMed Web of Science ®Google Scholar
• KobeltG, PugliattiM. Cost of multiple sclerosis in Europe. Eur J Neurol 2005;12:S63–S67.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The global burden of disease: 2004 update. Geneva: WHO; 2008.
   Google Scholar
• SimmonsRD, TribeKL, McDonaldEA. Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management. J Neurol 2010;257:926–936.
   PubMed Web of Science ®Google Scholar
• Messmer UccelliM, SpecchiaC, BattagliaMA, MillerDM. Factors that influence the employment status of people with multiple sclerosis: a multi-national study. J Neurol 2009;256:1989–1996.
   PubMed Web of Science ®Google Scholar
• JulianLJ, VellaL, VollmerT, HadjimichaelO, MohrDC. Employment in multiple sclerosis: exiting and re-entering the work force. J Neurol 2008;255:1354–1360.
   PubMed Web of Science ®Google Scholar
• TrojanoMD, PellegriniF, FuianiA, PaolicelliD, ZipoliV, ZimatoreGB, Di MonteE, PortaccioE, LeporeV, LivreaP, AmatoMP. New natural history of interferon-β treated relapsing multiple sclerosis. Ann Neurol 2007;61:300–306.
   PubMed Web of Science ®Google Scholar
• Andlin-SobockiP, JonssonB, WittchenHU, OlesenJ. Cost of disorders of the brain in Europe. Eur J Neurol 2005;12:S1–S27.
   PubMed Web of Science ®Google Scholar
• KurtzkeJF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–1452.
   PubMed Web of Science ®Google Scholar
• WyniaK, MiddelB, van DijkJP, de RuiterH, De KeyserJ, ReijneveldSA. The multiple sclerosis impact profile (MSIP). Development and testing psychometric properties of an ICF-based measure. Disabil Rehabil 2008;30:261–274.
   Google Scholar
• CohenJA, CutterGR, FischerJS, GoodmanAD, HeidenreichFR, JakAJ, KnikerJE, KooijmansMF, LullJM, SandrockAW, SimonJH, SimonianNA, WhitakerJN. Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Arch Neurol 2001;58:961–967.
   PubMed Web of Science ®Google Scholar
• RavnborgM, Grønbech-JensenM, JønssonA. The MS Impairment Scale: a pragmatic approach to the assessment of impairment in patients with multiple sclerosis. Mult Scler 1997;3:31–42.
   PubMed Web of Science ®Google Scholar
• SharrackB, HughesRA. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler 1999;5:223–233.
   PubMed Web of Science ®Google Scholar
• MumfordCJ, CompstonA. Problems with rating scales for multiple sclerosis: a novel approach – the CAMBS score. J Neurol 1993;240:209–215.
   PubMed Web of Science ®Google Scholar
• Langer-GouldA, PopatRA, HuangSM, CobbK, FontouraP, GouldMK, NelsonLM. Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review. Arch Neurol 2006;63:1686–1691.
   PubMed Web of Science ®Google Scholar
• Pittion-VouyovitchS, DebouverieM, GuilleminF, VandenbergheN, AnxionnatR, VespignaniH. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci 2006;243:39–45.
   PubMed Web of Science ®Google Scholar
• TworkS, WiesmethS, SpindlerM, WirtzM, SchipperS, PöhlauD, KlewerJ, KuglerJ. Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS). Health Qual Life Outcomes 2010;8:55.
   Web of Science ®Google Scholar
• HirstC, IngramG, SwinglerR, CompstonDA, PickersgillT, RobertsonNP. Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis. J Neurol Neurosurg Psychiatry 2008;79:1137–1143.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The international Classification of Functioning, Disability and Health: ICF. Geneva: WHO; 2001.
   Google Scholar
• KhanF, PallantJF. Use of the International Classification of Functioning, Disability and Health (ICF) to identify preliminary comprehensive and brief core sets for multiple sclerosis. Disabil Rehabil 2007;29:205–213.
   PubMed Web of Science ®Google Scholar
• HolperL, CoenenM, WeiseA, StuckiG, CiezaA, KesselringJ. Characterization of functioning in multiple sclerosis using the ICF. J Neurol 2010;257:103–113.
   PubMed Web of Science ®Google Scholar
• LeonardiM, BickenbachJ, UstunTB, KostanjsekN, ChatterjiS, on behalf of the MHADIE consortium. The definition of disability: what is in a name? Lancet 2006;368:1219–1221.
   PubMed Web of Science ®Google Scholar
• FrancescuttiC, FusaroG, LeonardiM, MartinuzziA, SalaM, RussoE, FrareM, PradalM, ZampognaD, CosentinoA, RaggiA. Italian ICF training programs: describing and promoting human functioning and research. Disabil Rehabil 2009;31:S46–S49.
   PubMed Web of Science ®Google Scholar
• MillerD, McDonaldI, SmithK. The diagnosis of multiple sclerosis. McAlpine's mltiple sclerosis. In: CompstonA, editor. 4th edChurchill Livingstone Elsevier; 2006. pp 347–386.
   Google Scholar
• AyusoJL, CabelloM, LeonardiM, RaggiA. Application of ICF in clinical settings across EuropeDisabil Rehabil; S17–S22.
   Google Scholar
• EwertT, FuesslM, CiezaA, AndersenC, ChatterjiS, KostanjsekN, StuckiG. Identification of the most common patient problems in patients with chronic conditions using the ICF checklist. J Rehabil Med 2004;(Suppl 44):22–29.
   PubMed Web of Science ®Google Scholar
• UstunTB, KostanjsekN, ChatterjiS, RehmJ. Measuring health and disability: Manual for WHO Disability Assessment Schedule (WHO-DAS II). Geneva: WHO; 2010
   Google Scholar
• GarinO, Ayuso-MateosJL, AlmansaJ, NietoM, ChatterjiS, VilagutG, AlonsoJ, CiezaA, SvestkovaO, BurgerH, RaccaV, FrancescuttiC, VietaE, KostanjsekN, RaggiA, LeonardiM, FerrerM, and the MHADIE consortium. Validation of the “World Health Organization Disability Assessment Schedule, WHODAS-2” in patients with chronic diseases. Health Qual Life Outcomes 2010;8:51.
   PubMed Web of Science ®Google Scholar
• TempestS, McIntyreA. Using the ICF to clarify team roles and demonstrate clinical reasoning in stroke rehabilitation. Disabil Rehabil 2006;28:663–667.
   PubMed Web of Science ®Google Scholar
• RentschHP, BucherP, Dommen NyffelerI, WolfC, HeftiH, FluriE, WengerU, WaltiC, BoyerI. The implementation of the ‘International Classification of Functioning, Disability and Health’ (ICF) in daily practice of neurorehabilitation: an interdisciplinary project at the Kantonsspital of Lucerne, Switzerland. Disabil Rehabil 2003;25:411–421.
   PubMed Web of Science ®Google Scholar